We deliver the formulation. Full stop.
Our scope ends at a manufacturer-ready formulation package. The three iterations and the Acceptance Certificate define exactly what you receive and when our obligations conclude.
Most formulation firms blur the line between R&D services and manufacturing. They take title to your inventory, process your funds, or sign your co-man contracts on your behalf. That blur creates exposure on both sides — for them and for you.
Lotus Nutra is built differently. Under Path A architecture, the line is sharp on purpose: we deliver the IP, you select your co-man, your contract is with them.
Our scope ends at a manufacturer-ready formulation package. The three iterations and the Acceptance Certificate define exactly what you receive and when our obligations conclude.
We introduce vetted co-mans from our network and forward their certificates of insurance as courtesy disclosure. You decide who you contract with; we never broker the relationship.
Their COI covers their work; your product liability covers yours. The insurance lineage is legible and the manufacturer-of-record sits where it belongs — with the manufacturer.
We never take title to inventory, process customer funds, or sign co-man contracts on your behalf. The line that separates R&D from manufacturing stays sharp.
Funded brands need a clean liability story. Path A delivers one: the formulation IP is bought-and-paid-for; the manufacturer is on your contract; your insurance lineage is clear; your Acceptance Certificate marks the exact boundary of our involvement.
That’s the story your diligence team wants to read — not a vague “formulation partner” relationship that could be re-characterized at audit.
Lotus Nutra is headquartered in Tampa, Florida. We formulate beverage and gummy products for brands in the functional, adaptogenic, kava, kratom, and cannabinoid spaces.
We’ll respond within two business days with scope, timeline, and a draft tier recommendation.